ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,719.66
      0.30%
      US Tech 100
      19,320.00
      0.12%
      Dow Jones
      42,119.85
      0.13%
      Brent Oil
      73.565
      -0.43%
      Bitcoin
      63,510.16
      -0.18%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE
      6. Taro Pharmaceutical Industries Ltd (TARO)

      7. Taro Pharmaceutical Industries Ltd (TARO) Financials

      Taro Pharmaceutical Industries Ltd

      Taro Pharmaceutical Industries Ltd (TARO)

      NYSE
      42.97
      0.00
      ( 0.00% )
      Updated: 20:00:00
      Delayed by 15 minutes

      Taro Pharmaceutical Industries Ltd Financial Summary

      The current TARO market cap is 1.61B. The company's latest EPS is USD 1.4334 and P/E is 29.98.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 146.59M158.89M148.2M157.15M164.94M
      Operating Income 9.27M-7.92M4.74M15.91M8.79M
      Net Income 6.91M10.03M8.55M20.21M15.08M
      Year End March 30 2024 20202021202220232024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 644.77M548.97M561.35M572.95M629.18M
      Operating Income 246.54M-413.78M63.47M17.71M21.51M
      Net Income 244.24M-386.65M58.27M25.45M53.87M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 2.14B2.14B2.12B2.16B2.16B
      Total Liabilities 404.66M396.52M371.92M384.09M369.06M
      Total Equity 1.73B1.74B1.75B1.78B1.79B
      Year End March 30 2024 20202021202220232024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 2.34B2.41B2.18B2.14B2.16B
      Total Liabilities 231.49M711.42M464.92M404.65M369.06M
      Total Equity 2.11B1.7B1.71B1.73B1.79B

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating 31.75M7.78M55.29M86.22M124.56M
      Investing -125.56M-38.7M59.87M141.54M84.34M
      Financing N/A N/A N/A N/A N/A
      Year End March 30 2024 20202021202220232024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating 271.61M45.77M-158.7M31.75M124.56M
      Investing -298.16M67.74M-170.58M-125.56M84.34M
      Financing -26.98M-24.2M-24.93M N/A N/A

      Stats and Ratios

      Market Cap 1.61B
      Price to Earnings Ratio 29.98
      Price to Sales Ratio 2.57
      Price to Cash Ratio 4.45
      Price to Book Ratio 0.9
      Dividend Yield -

      Share Statistics

      Shares Outstanding 37.58M
      Average Volume (1 week) 0
      Average Volume (1 Month) 0
      52 Week Change 13.98%
      52 Week High 45.76
      52 Week Low 32.67
      Spread (Intraday) 2.47 (5.62%)

      Company Info

      Company Name Taro Pharmaceutical Industries Ltd
      Address 14 hakitor street
      haifa, north 2624761
      Website https://www.taro.com
      Industry pharmaceutical preparations (2834)

      Your Recent History

      NYSE
      TARO
      Taro Pharmaceutical Indu...
      Delayed Upgrade Clock